Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Weaver

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Pageof 6